Aprotinin and the systemic inflammatory response after cardiopulmonary bypass (Q32110935)

6 July 2017

1 reference

title

Aprotinin and the systemic inflammatory response after cardiopulmonary bypass (English)

1 reference

6 July 2017

Mojcik CF

1

1 reference

6 July 2017

Levy JH

series ordinal

2

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

The Annals of Thoracic Surgery

6 July 2017

published in

1 reference

6 July 2017

volume

71

1 reference

6 July 2017

issue

2

1 reference

6 July 2017

page(s)

745-754

1 reference

Studies in extracorporeal circulation. I. Applicability of Gibbon-type pump-oxygenator to human intracardiac surgery: 40 cases

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Systemic inflammatory responses to surgery with cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Cardiopulmonary bypass: studies on its damaging effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Preventing the inflammatory response to open-heart surgery: the role of aprotinin and other protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Purified human plasma kallikrein aggregates human blood neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Different activation patterns in the plasma kallikrein-kinin and complement systems during coronary bypass surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Aprotinin in cardiopulmonary bypass--effects on the Hageman factor (FXII)--Kallikrein system and blood loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Release of vasoactive substances during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Influence of heparin, heparin plus aprotinin and hirudin on contact activation in a cardiopulmonary bypass model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial Revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Bradykinin stimulates tissue plasminogen activator release in human vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Endothelial cell injury in cardiovascular surgery: the procoagulant response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Inflammatory response to cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Activation of the classical pathway of complement by Hageman factor fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Complement activation and lung permeability during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Controlling the complement system in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Effects of aprotinin on complement and granulocyte activation during ex vivo hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Transendothelial neutrophil migration. Role of neutrophil-derived proteases and relationship to transendothelial protein movement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Complement and leukocytes during cardiopulmonary bypass: effects on plasma C3d and C5a, leukocyte count, release of granulocyte elastase and granulocyte chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Aprotinin diminishes inflammatory processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Pump prime only aprotinin inhibits cardiopulmonary bypass-induced neutrophil CD11b up-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

The platelet in cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

7 January 2021

Aprotinin in perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Blood contact activation: pathophysiological effects and therapeutic approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Aprotinin reduces the expression of p-selectin on the surface of platelet and leukocyte-platelet conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Steroid Inhibition of Cytokine-Mediated Vasodilation After Warm Heart Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Aprotinin enhances the endogenous release of interleukin-10 after cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

Cardiopulmonary bypass and the inflammatory response: a role for serine protease inhibitors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2902218-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-4975(00)02218-9

1 reference

6 July 2017

1 reference